ATE246185T1 - Polymorphes salz eines anti-migrainemittels - Google Patents

Polymorphes salz eines anti-migrainemittels

Info

Publication number
ATE246185T1
ATE246185T1 AT00954864T AT00954864T ATE246185T1 AT E246185 T1 ATE246185 T1 AT E246185T1 AT 00954864 T AT00954864 T AT 00954864T AT 00954864 T AT00954864 T AT 00954864T AT E246185 T1 ATE246185 T1 AT E246185T1
Authority
AT
Austria
Prior art keywords
polymorphous
salt
migraine agent
migraine
agent
Prior art date
Application number
AT00954864T
Other languages
English (en)
Inventor
Arthur Bentley
Simon Arnold Howard-Field
Ronald James Ogilvie
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Application granted granted Critical
Publication of ATE246185T1 publication Critical patent/ATE246185T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
    • A61K31/404—Indoles, e.g. pindolol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/08—Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/14—Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/02—Nasal agents, e.g. decongestants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/06—Antimigraine agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Pain & Pain Management (AREA)
  • Otolaryngology (AREA)
  • Psychiatry (AREA)
  • Cardiology (AREA)
  • Pulmonology (AREA)
  • Addiction (AREA)
  • Obesity (AREA)
  • Diabetes (AREA)
  • Child & Adolescent Psychology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Anesthesiology (AREA)
  • Rheumatology (AREA)
  • Hospice & Palliative Care (AREA)
  • Hematology (AREA)
  • Nutrition Science (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Steroid Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
AT00954864T 1999-09-28 2000-09-14 Polymorphes salz eines anti-migrainemittels ATE246185T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB9922963.5A GB9922963D0 (en) 1999-09-28 1999-09-28 Polymorphic salt
PCT/IB2000/001305 WO2001023377A2 (en) 1999-09-28 2000-09-14 Polymorphic salt

Publications (1)

Publication Number Publication Date
ATE246185T1 true ATE246185T1 (de) 2003-08-15

Family

ID=10861767

Family Applications (1)

Application Number Title Priority Date Filing Date
AT00954864T ATE246185T1 (de) 1999-09-28 2000-09-14 Polymorphes salz eines anti-migrainemittels

Country Status (50)

Country Link
US (1) US6369094B1 (de)
EP (1) EP1233960B1 (de)
JP (1) JP3795395B2 (de)
KR (1) KR100479897B1 (de)
CN (1) CN1155594C (de)
AP (1) AP2004A (de)
AR (1) AR025779A1 (de)
AT (1) ATE246185T1 (de)
AU (1) AU779580B2 (de)
BG (1) BG65161B1 (de)
BR (1) BR0014272A (de)
CA (1) CA2379572C (de)
CO (1) CO5180567A1 (de)
CR (1) CR6561A (de)
CU (1) CU23200A3 (de)
CZ (1) CZ2002971A3 (de)
DE (1) DE60004262T2 (de)
DK (1) DK1233960T3 (de)
DZ (1) DZ3254A1 (de)
EA (1) EA004510B1 (de)
EE (1) EE200200171A (de)
EG (1) EG24143A (de)
ES (1) ES2200911T3 (de)
GB (1) GB9922963D0 (de)
GE (1) GEP20043365B (de)
GT (1) GT200000159A (de)
HK (1) HK1048628B (de)
HR (1) HRP20020270B1 (de)
HU (1) HUP0202821A3 (de)
IL (1) IL147154A (de)
IS (1) IS2162B (de)
MA (1) MA26821A1 (de)
MX (1) MXPA02003311A (de)
MY (1) MY121170A (de)
NO (1) NO321936B1 (de)
NZ (1) NZ516093A (de)
OA (1) OA12024A (de)
PA (1) PA8498901A1 (de)
PE (1) PE20010662A1 (de)
PL (1) PL354960A1 (de)
PT (1) PT1233960E (de)
SI (1) SI1233960T1 (de)
SK (1) SK3982002A3 (de)
TN (1) TNSN00187A1 (de)
TR (1) TR200200804T2 (de)
TW (1) TWI265926B (de)
UA (1) UA72272C2 (de)
WO (1) WO2001023377A2 (de)
YU (1) YU2602A (de)
ZA (1) ZA200202406B (de)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20060025387A1 (en) * 1998-12-23 2006-02-02 Cytoscan Sciences Llc Compositions and methods for the treatment of disorders of the central and peripheral nervous systems
US8722668B2 (en) * 1998-12-23 2014-05-13 Daryl W. Hochman Methods and compositions for the treatment of neuropathic pain and neuropsychiatric disorders
US7214711B2 (en) * 1998-12-23 2007-05-08 Neurotherapeutics Pharma Llc Method of treating migraine headache without aura
US8008283B2 (en) * 1998-12-23 2011-08-30 Neurotherapeutics Pharma, Inc. Methods and compositions for the treatment of neuropsychiatric disorders
GB0018968D0 (en) * 2000-08-02 2000-09-20 Pfizer Ltd Particulate composition
US7132549B2 (en) 2003-05-30 2006-11-07 Pfizer Inc. Process
GB0312478D0 (en) * 2003-05-30 2003-07-09 Pfizer Ltd Improved process
ES2727577T5 (en) * 2004-12-03 2025-04-02 Merck Sharp & Dohme Llc Pharmaceutical composition containing an anti-nucleating agent
US20070149526A1 (en) * 2005-10-17 2007-06-28 Neurotherapeutics Pharma, L.L.C. Diuretic and diuretic-like compound analogs
KR100814109B1 (ko) * 2006-01-09 2008-03-14 한국생명공학연구원 로다닌 유도체, 이의 제조방법 및 이를 유효성분으로함유하는 약학적 조성물
TWI394753B (zh) 2006-03-17 2013-05-01 Otsuka Pharma Co Ltd 新穎替妥牟拉（ｔｅｔｏｍｉｌａｓｔ）晶體
WO2010116386A2 (en) * 2009-04-08 2010-10-14 Biophore India Pharmaceuticals Pvt. Ltd. Novel polymorph of eletriptan hydrobromide and process for the preparation thereof
EP3970702A1 (de) 2009-10-26 2022-03-23 Merck Sharp & Dohme Corp. Feste pharmazeutische zusammensetzungen mit einem integrasehemmer

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5559246A (en) 1990-10-15 1996-09-24 Pfizer Inc. Indole derivatives
PL168919B1 (pl) * 1990-10-15 1996-05-31 Pfizer Sposób wytwarzania nowych pochodnych indolu PL PL PL PL
US5559129A (en) 1990-10-15 1996-09-24 Pfizer Inc Indole derivatives
US5545644A (en) 1990-10-15 1996-08-13 Pfizer Inc. Indole derivatives
US5578612A (en) 1990-10-15 1996-11-26 Pfizer Inc. Indole derivatives
US5607951A (en) 1990-10-15 1997-03-04 Pfizer Inc Indole derivatives
GB9417310D0 (en) * 1994-08-27 1994-10-19 Pfizer Ltd Therapeutic agents
US5998462A (en) * 1996-12-16 1999-12-07 Allelix Biopharmaceuticals Inc. 5-alkyl indole compounds
JP3350061B2 (ja) 1997-07-03 2002-11-25 ファイザー・インク エレトリプタンヘミスルフェートおよびカフェインを含有する医薬組成物

Also Published As

Publication number Publication date
CU23200A3 (es) 2007-04-06
IL147154A (en) 2005-11-20
CN1155594C (zh) 2004-06-30
JP3795395B2 (ja) 2006-07-12
DK1233960T3 (da) 2003-10-27
AP2004A (en) 2009-06-10
DZ3254A1 (fr) 2001-04-05
CA2379572A1 (en) 2001-04-05
IS2162B (is) 2006-11-15
HK1048628A1 (en) 2003-04-11
BG106240A (en) 2002-07-31
CR6561A (es) 2005-04-04
EP1233960B1 (de) 2003-07-30
PA8498901A1 (es) 2004-02-07
HUP0202821A3 (en) 2003-12-29
NO20021525D0 (no) 2002-03-26
IS6223A (is) 2002-01-08
GB9922963D0 (en) 1999-12-01
TWI265926B (en) 2006-11-11
HRP20020270B1 (en) 2004-04-30
SI1233960T1 (en) 2003-12-31
GT200000159A (es) 2002-03-20
BG65161B1 (bg) 2007-04-30
EP1233960A2 (de) 2002-08-28
WO2001023377A3 (en) 2002-03-07
TR200200804T2 (tr) 2002-07-22
KR20020032627A (ko) 2002-05-03
DE60004262D1 (de) 2003-09-04
CN1364166A (zh) 2002-08-14
NO321936B1 (no) 2006-07-24
TNSN00187A1 (fr) 2005-11-10
YU2602A (sh) 2004-11-25
MA26821A1 (fr) 2004-12-20
NZ516093A (en) 2005-01-28
EA200200302A1 (ru) 2002-10-31
EE200200171A (et) 2003-06-16
CO5180567A1 (es) 2002-07-30
HUP0202821A2 (hu) 2003-01-28
OA12024A (en) 2006-04-19
MXPA02003311A (es) 2002-10-04
PL354960A1 (en) 2004-03-22
NO20021525L (no) 2002-03-26
PT1233960E (pt) 2003-11-28
CZ2002971A3 (cs) 2003-04-16
KR100479897B1 (ko) 2005-03-31
ZA200202406B (en) 2003-05-28
EA004510B1 (ru) 2004-04-29
IL147154A0 (en) 2002-08-14
AR025779A1 (es) 2002-12-11
GEP20043365B (en) 2004-05-10
DE60004262T2 (de) 2004-01-22
WO2001023377A2 (en) 2001-04-05
AP2002002457A0 (en) 2002-06-30
SK3982002A3 (en) 2003-05-02
BR0014272A (pt) 2002-05-21
AU779580B2 (en) 2005-01-27
UA72272C2 (uk) 2005-02-15
ES2200911T3 (es) 2004-03-16
EG24143A (en) 2008-08-06
PE20010662A1 (es) 2001-06-23
HK1048628B (zh) 2004-10-21
HRP20020270A2 (en) 2003-06-30
AU6721300A (en) 2001-04-30
US6369094B1 (en) 2002-04-09
WO2001023377A9 (en) 2002-03-28
MY121170A (en) 2005-12-30
JP2003510318A (ja) 2003-03-18
CA2379572C (en) 2006-11-14

Similar Documents

Publication Publication Date Title
DE69920009D1 (de) Isothiazole derivate verwendbar als antikrebsmittel
MA26816A1 (fr) Derives d'amino-triazolopyridine
DK1163237T3 (da) Amidderivater
ATE263549T1 (de) Essbares überzugsmittel
DE60006576D1 (de) Teilweise oder vollständige a1 agonisten - n6-heterocyclische 5'-thio sustituierte adenosinderivate
DE69937967D1 (de) Wässrige überzugszusammensetzungen
DE69930518D1 (de) Als antikrebsmittel verwendbare alkinyl-substituierte chinolin-2-on-derivate
DK1244641T3 (da) Thiazolylamid-derivater
DE59803721D1 (de) Beschichteter Gusskörper
ID26277A (id) Turunan-turunan kuinolina
ATE246185T1 (de) Polymorphes salz eines anti-migrainemittels
ATE233746T1 (de) Thiazole derivate
EP1163852A4 (de) Maskierungsmittel
NO20013684D0 (no) Substituerte fenetylaminderivater
DE69910459D1 (de) Innenbelagzusammensetzung eines Reifens
DE69932920D1 (de) Neue dihydroxyhexansäurederivate
ATA217199A (de) Wässriges überzugsmittel
ATE243190T1 (de) Phenyl-methoxyimino-essigsäurederivate als pestizide
ITMI980333U1 (it) Struttura perfezionata di suola adatta alla traspirazione
PT1069885E (pt) Solucao oftalmica que compreende glicogenio
ATE266012T1 (de) Thiazole derivate
PT1178984E (pt) Derivados de 1-trifluorometil-4-hidroxi-7-piperidinilamimometilcromano
DE50010602D1 (de) Regelung eines ottomotors
ATE243218T1 (de) 2''-deoxyhygromycinderivate
ATE217621T1 (de) Thiazol-derivate

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1233960

Country of ref document: EP

REN Ceased due to non-payment of the annual fee